Concepedia

Author

U Hess

Goethe University Frankfurt

Also Known As

U Hess, U. Hess, Uwe Hess

13

Publications

405

Citations

9

H-Index

13

Concepts

All Affiliations

Goethe University FrankfurtKantonsspital St. Gallen
UH

About

U Hess is an author at Goethe University Frankfurt specializing in hematology, medicine, and genetic testing.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

59

2

Health Sciences

1

1

14

3

Emergency Medicine

1

1

14

4

Immunology

1

1

32

5

Pathology

1

1

13

U Hess

×

8

Publications

372

Citations

8

H-Index

YearCitations

Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.

Bob Löwenberg, M. Boogaerts, Simon Daenen,

Journal of Clinical Oncology

1997

128

Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony- stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study

Arnold Ganser, A. Lindemann, G. Seipelt,

Blood

1992

76

Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromes.

Arnold Ganser, Oliver G. Ottmann, G. Seipelt,

PubMed

1993

45

Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes.

Arnold Ganser, G. Seipelt, Walter Verbeek,

PubMed

1994

42

MYELOKATHEXIS TREATED WITH RECOMBINANT HUMAN GRANULOCYTE‐MACROPHAGE COLONY‐STIMULATING FACTOR (rhGM‐CSF)

U Hess, A. Ganser, Schnürch Hg,

British Journal of Haematology

1992

32

Treatment of myelodysplastic syndromes with cytokines and cytotoxic drugs.

Arnold Ganser, G. Seipelt, M Eder,

PubMed

1992

22

Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies

Margriet Oosterveld, Stefan Suciu, Petra Muus,

Annals of Hematology

2014

14

Combination of broad molecular screening and cytogenetic analysis for genetic risk assignment and diagnosis in patients with acute leukemia

Sandrine Meyer‐Monard, V. Parlier, Jakob Passweg,

Leukemia

2006

13

Page 1